aluates Reports

$ 0.0

Automative

Global Oral Solid Dosage Formulation Development Service Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-15J14210

Global Oral Solid Dosage Formulation Development Service Market Research Report 2023

BUY CHAPTERS

Global Oral Solid Dosage Formulation Development Service Market Research Report 2025

Code: QYRE-Auto-15J14210

Report

April 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Evonik Industries

Aurigene Pharmaceutical Services

Thermo Fisher Scientific

Recipeharm

UPM Pharmaceuticals

Almac Group

Alcami

Lonza

Catalent

Societal

Skyepharma Production

Crystal Pharmatech

Ascendia

Oral Solid Dosage Formulation Development Service Market Size

The global market for Oral Solid Dosage Formulation Development Service was valued at US$ 226 million in the year 2024 and is projected to reach a revised size of US$ 285 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Oral Solid Dosage Formulation Development Service Market

North American market for Oral Solid Dosage Formulation Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral Solid Dosage Formulation Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Oral Solid Dosage Formulation Development Service in SMEs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oral Solid Dosage Formulation Development Service include Pfizer, Evonik Industries, Societal, Aurigene Pharmaceutical Services, Thermo Fisher Scientific, Skyepharma Production, Recipeharm, UPM Pharmaceuticals, Crystal Pharmatech, Almac Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Formulation Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Formulation Development Service.

The Oral Solid Dosage Formulation Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Solid Dosage Formulation Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Solid Dosage Formulation Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Solid Dosage Formulation Development Service Market Report

Report Metric	Details
Report Name	Oral Solid Dosage Formulation Development Service Market
Accounted market size in year	US$ 226 million
Forecasted market size in 2031	US$ 285 million
CAGR	3.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tablet Capsule Powder
Segment by Application	SMEs Large Enterprises
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Evonik Industries, Societal, Aurigene Pharmaceutical Services, Thermo Fisher Scientific, Skyepharma Production, Recipeharm, UPM Pharmaceuticals, Crystal Pharmatech, Almac Group, Alcami, Lonza, Catalent, Ascendia
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Solid Dosage Formulation Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Solid Dosage Formulation Development Service Market growing?

Ans: The Oral Solid Dosage Formulation Development Service Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Oral Solid Dosage Formulation Development Service Market size in 2031?

Ans: The Oral Solid Dosage Formulation Development Service Market size in 2031 will be US$ 285 million.

Who are the main players in the Oral Solid Dosage Formulation Development Service Market report?

Ans: The main players in the Oral Solid Dosage Formulation Development Service Market are Pfizer, Evonik Industries, Societal, Aurigene Pharmaceutical Services, Thermo Fisher Scientific, Skyepharma Production, Recipeharm, UPM Pharmaceuticals, Crystal Pharmatech, Almac Group, Alcami, Lonza, Catalent, Ascendia

What are the Application segmentation covered in the Oral Solid Dosage Formulation Development Service Market report?

Ans: The Applications covered in the Oral Solid Dosage Formulation Development Service Market report are SMEs, Large Enterprises

What are the Type segmentation covered in the Oral Solid Dosage Formulation Development Service Market report?

Ans: The Types covered in the Oral Solid Dosage Formulation Development Service Market report are Tablet, Capsule, Powder

Recommended Reports

Oral Drug Delivery

Formulation & Excipients

Oral Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tablet

1.2.3 Capsule

1.2.4 Powder

1.3 Market by Application

1.3.1 Global Oral Solid Dosage Formulation Development Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 SMEs

1.3.3 Large Enterprises

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Solid Dosage Formulation Development Service Market Perspective (2020-2031)

2.2 Global Oral Solid Dosage Formulation Development Service Growth Trends by Region

2.2.1 Global Oral Solid Dosage Formulation Development Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Solid Dosage Formulation Development Service Historic Market Size by Region (2020-2025)

2.2.3 Oral Solid Dosage Formulation Development Service Forecasted Market Size by Region (2026-2031)

2.3 Oral Solid Dosage Formulation Development Service Market Dynamics

2.3.1 Oral Solid Dosage Formulation Development Service Industry Trends

2.3.2 Oral Solid Dosage Formulation Development Service Market Drivers

2.3.3 Oral Solid Dosage Formulation Development Service Market Challenges

2.3.4 Oral Solid Dosage Formulation Development Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Solid Dosage Formulation Development Service Players by Revenue

3.1.1 Global Top Oral Solid Dosage Formulation Development Service Players by Revenue (2020-2025)

3.1.2 Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Players (2020-2025)

3.2 Global Oral Solid Dosage Formulation Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Solid Dosage Formulation Development Service Revenue

3.4 Global Oral Solid Dosage Formulation Development Service Market Concentration Ratio

3.4.1 Global Oral Solid Dosage Formulation Development Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Formulation Development Service Revenue in 2024

3.5 Global Key Players of Oral Solid Dosage Formulation Development Service Head office and Area Served

3.6 Global Key Players of Oral Solid Dosage Formulation Development Service, Product and Application

3.7 Global Key Players of Oral Solid Dosage Formulation Development Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Solid Dosage Formulation Development Service Breakdown Data by Type

4.1 Global Oral Solid Dosage Formulation Development Service Historic Market Size by Type (2020-2025)

4.2 Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Type (2026-2031)

5 Oral Solid Dosage Formulation Development Service Breakdown Data by Application

5.1 Global Oral Solid Dosage Formulation Development Service Historic Market Size by Application (2020-2025)

5.2 Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Solid Dosage Formulation Development Service Market Size (2020-2031)

6.2 North America Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)

6.4 North America Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Solid Dosage Formulation Development Service Market Size (2020-2031)

7.2 Europe Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)

7.4 Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size (2020-2031)

8.2 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Solid Dosage Formulation Development Service Market Size (2020-2031)

9.2 Latin America Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)

9.4 Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size (2020-2031)

10.2 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Oral Solid Dosage Formulation Development Service Introduction

11.1.4 Pfizer Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Evonik Industries

11.2.1 Evonik Industries Company Details

11.2.2 Evonik Industries Business Overview

11.2.3 Evonik Industries Oral Solid Dosage Formulation Development Service Introduction

11.2.4 Evonik Industries Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.2.5 Evonik Industries Recent Development

11.3 Societal

11.3.1 Societal Company Details

11.3.2 Societal Business Overview

11.3.3 Societal Oral Solid Dosage Formulation Development Service Introduction

11.3.4 Societal Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.3.5 Societal Recent Development

11.4 Aurigene Pharmaceutical Services

11.4.1 Aurigene Pharmaceutical Services Company Details

11.4.2 Aurigene Pharmaceutical Services Business Overview

11.4.3 Aurigene Pharmaceutical Services Oral Solid Dosage Formulation Development Service Introduction

11.4.4 Aurigene Pharmaceutical Services Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.4.5 Aurigene Pharmaceutical Services Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Details

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Oral Solid Dosage Formulation Development Service Introduction

11.5.4 Thermo Fisher Scientific Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 Skyepharma Production

11.6.1 Skyepharma Production Company Details

11.6.2 Skyepharma Production Business Overview

11.6.3 Skyepharma Production Oral Solid Dosage Formulation Development Service Introduction

11.6.4 Skyepharma Production Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.6.5 Skyepharma Production Recent Development

11.7 Recipeharm

11.7.1 Recipeharm Company Details

11.7.2 Recipeharm Business Overview

11.7.3 Recipeharm Oral Solid Dosage Formulation Development Service Introduction

11.7.4 Recipeharm Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.7.5 Recipeharm Recent Development

11.8 UPM Pharmaceuticals

11.8.1 UPM Pharmaceuticals Company Details

11.8.2 UPM Pharmaceuticals Business Overview

11.8.3 UPM Pharmaceuticals Oral Solid Dosage Formulation Development Service Introduction

11.8.4 UPM Pharmaceuticals Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.8.5 UPM Pharmaceuticals Recent Development

11.9 Crystal Pharmatech

11.9.1 Crystal Pharmatech Company Details

11.9.2 Crystal Pharmatech Business Overview

11.9.3 Crystal Pharmatech Oral Solid Dosage Formulation Development Service Introduction

11.9.4 Crystal Pharmatech Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.9.5 Crystal Pharmatech Recent Development

11.10 Almac Group

11.10.1 Almac Group Company Details

11.10.2 Almac Group Business Overview

11.10.3 Almac Group Oral Solid Dosage Formulation Development Service Introduction

11.10.4 Almac Group Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.10.5 Almac Group Recent Development

11.11 Alcami

11.11.1 Alcami Company Details

11.11.2 Alcami Business Overview

11.11.3 Alcami Oral Solid Dosage Formulation Development Service Introduction

11.11.4 Alcami Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.11.5 Alcami Recent Development

11.12 Lonza

11.12.1 Lonza Company Details

11.12.2 Lonza Business Overview

11.12.3 Lonza Oral Solid Dosage Formulation Development Service Introduction

11.12.4 Lonza Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.12.5 Lonza Recent Development

11.13 Catalent

11.13.1 Catalent Company Details

11.13.2 Catalent Business Overview

11.13.3 Catalent Oral Solid Dosage Formulation Development Service Introduction

11.13.4 Catalent Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.13.5 Catalent Recent Development

11.14 Ascendia

11.14.1 Ascendia Company Details

11.14.2 Ascendia Business Overview

11.14.3 Ascendia Oral Solid Dosage Formulation Development Service Introduction

11.14.4 Ascendia Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)

11.14.5 Ascendia Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Evonik Industries

Aurigene Pharmaceutical Services

Thermo Fisher Scientific

Recipeharm

UPM Pharmaceuticals

Almac Group

Alcami

Lonza

Catalent

Societal

Skyepharma Production

Crystal Pharmatech

Ascendia

List of Tables

Table 1. Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tablet

Table 3. Key Players of Capsule

Table 4. Key Players of Powder

Table 5. Global Oral Solid Dosage Formulation Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oral Solid Dosage Formulation Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Solid Dosage Formulation Development Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oral Solid Dosage Formulation Development Service Market Share by Region (2020-2025)

Table 9. Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oral Solid Dosage Formulation Development Service Market Share by Region (2026-2031)

Table 11. Oral Solid Dosage Formulation Development Service Market Trends

Table 12. Oral Solid Dosage Formulation Development Service Market Drivers

Table 13. Oral Solid Dosage Formulation Development Service Market Challenges

Table 14. Oral Solid Dosage Formulation Development Service Market Restraints

Table 15. Global Oral Solid Dosage Formulation Development Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oral Solid Dosage Formulation Development Service Market Share by Players (2020-2025)

Table 17. Global Top Oral Solid Dosage Formulation Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Formulation Development Service as of 2024)

Table 18. Ranking of Global Top Oral Solid Dosage Formulation Development Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oral Solid Dosage Formulation Development Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oral Solid Dosage Formulation Development Service, Headquarters and Area Served

Table 21. Global Key Players of Oral Solid Dosage Formulation Development Service, Product and Application

Table 22. Global Key Players of Oral Solid Dosage Formulation Development Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oral Solid Dosage Formulation Development Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Type (2020-2025)

Table 26. Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Type (2026-2031)

Table 28. Global Oral Solid Dosage Formulation Development Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Application (2020-2025)

Table 30. Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Application (2026-2031)

Table 32. North America Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Oral Solid Dosage Formulation Development Service Product

Table 50. Pfizer Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Evonik Industries Company Details

Table 53. Evonik Industries Business Overview

Table 54. Evonik Industries Oral Solid Dosage Formulation Development Service Product

Table 55. Evonik Industries Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 56. Evonik Industries Recent Development

Table 57. Societal Company Details

Table 58. Societal Business Overview

Table 59. Societal Oral Solid Dosage Formulation Development Service Product

Table 60. Societal Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 61. Societal Recent Development

Table 62. Aurigene Pharmaceutical Services Company Details

Table 63. Aurigene Pharmaceutical Services Business Overview

Table 64. Aurigene Pharmaceutical Services Oral Solid Dosage Formulation Development Service Product

Table 65. Aurigene Pharmaceutical Services Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 66. Aurigene Pharmaceutical Services Recent Development

Table 67. Thermo Fisher Scientific Company Details

Table 68. Thermo Fisher Scientific Business Overview

Table 69. Thermo Fisher Scientific Oral Solid Dosage Formulation Development Service Product

Table 70. Thermo Fisher Scientific Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 71. Thermo Fisher Scientific Recent Development

Table 72. Skyepharma Production Company Details

Table 73. Skyepharma Production Business Overview

Table 74. Skyepharma Production Oral Solid Dosage Formulation Development Service Product

Table 75. Skyepharma Production Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 76. Skyepharma Production Recent Development

Table 77. Recipeharm Company Details

Table 78. Recipeharm Business Overview

Table 79. Recipeharm Oral Solid Dosage Formulation Development Service Product

Table 80. Recipeharm Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 81. Recipeharm Recent Development

Table 82. UPM Pharmaceuticals Company Details

Table 83. UPM Pharmaceuticals Business Overview

Table 84. UPM Pharmaceuticals Oral Solid Dosage Formulation Development Service Product

Table 85. UPM Pharmaceuticals Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 86. UPM Pharmaceuticals Recent Development

Table 87. Crystal Pharmatech Company Details

Table 88. Crystal Pharmatech Business Overview

Table 89. Crystal Pharmatech Oral Solid Dosage Formulation Development Service Product

Table 90. Crystal Pharmatech Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 91. Crystal Pharmatech Recent Development

Table 92. Almac Group Company Details

Table 93. Almac Group Business Overview

Table 94. Almac Group Oral Solid Dosage Formulation Development Service Product

Table 95. Almac Group Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 96. Almac Group Recent Development

Table 97. Alcami Company Details

Table 98. Alcami Business Overview

Table 99. Alcami Oral Solid Dosage Formulation Development Service Product

Table 100. Alcami Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 101. Alcami Recent Development

Table 102. Lonza Company Details

Table 103. Lonza Business Overview

Table 104. Lonza Oral Solid Dosage Formulation Development Service Product

Table 105. Lonza Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 106. Lonza Recent Development

Table 107. Catalent Company Details

Table 108. Catalent Business Overview

Table 109. Catalent Oral Solid Dosage Formulation Development Service Product

Table 110. Catalent Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 111. Catalent Recent Development

Table 112. Ascendia Company Details

Table 113. Ascendia Business Overview

Table 114. Ascendia Oral Solid Dosage Formulation Development Service Product

Table 115. Ascendia Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025) & (US$ Million)

Table 116. Ascendia Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Oral Solid Dosage Formulation Development Service Picture

Figure 2. Global Oral Solid Dosage Formulation Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Solid Dosage Formulation Development Service Market Share by Type: 2024 VS 2031

Figure 4. Tablet Features

Figure 5. Capsule Features

Figure 6. Powder Features

Figure 7. Global Oral Solid Dosage Formulation Development Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oral Solid Dosage Formulation Development Service Market Share by Application: 2024 VS 2031

Figure 9. SMEs Case Studies

Figure 10. Large Enterprises Case Studies

Figure 11. Oral Solid Dosage Formulation Development Service Report Years Considered

Figure 12. Global Oral Solid Dosage Formulation Development Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Oral Solid Dosage Formulation Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Oral Solid Dosage Formulation Development Service Market Share by Region: 2024 VS 2031

Figure 15. Global Oral Solid Dosage Formulation Development Service Market Share by Players in 2024

Figure 16. Global Top Oral Solid Dosage Formulation Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Formulation Development Service as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Oral Solid Dosage Formulation Development Service Revenue in 2024

Figure 18. North America Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Oral Solid Dosage Formulation Development Service Market Share by Country (2020-2031)

Figure 20. United States Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Oral Solid Dosage Formulation Development Service Market Share by Country (2020-2031)

Figure 24. Germany Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Oral Solid Dosage Formulation Development Service Market Share by Region (2020-2031)

Figure 32. China Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Oral Solid Dosage Formulation Development Service Market Share by Country (2020-2031)

Figure 40. Mexico Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Oral Solid Dosage Formulation Development Service Market Share by Country (2020-2031)

Figure 44. Turkey Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Oral Solid Dosage Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 48. Evonik Industries Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 49. Societal Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 50. Aurigene Pharmaceutical Services Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 52. Skyepharma Production Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 53. Recipeharm Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 54. UPM Pharmaceuticals Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 55. Crystal Pharmatech Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 56. Almac Group Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 57. Alcami Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 58. Lonza Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 59. Catalent Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 60. Ascendia Revenue Growth Rate in Oral Solid Dosage Formulation Development Service Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Solid Dosage Manufacturing Market Research Report 2025

Global Formulation Development Service Market Research Report 2025

Global Oral Sustained and Controlled Release Formulations Market Research Report 2025

Liposomal Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Controlled Release Drug Delivery Technology Market Research Report 2024

Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Solid Precursors and Delivery Systems Market Research Report 2024

Sterile Formulation Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sustained and Controlled Release Formulations Market Research Report 2025

Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Formulation Development Market Research Report 2025

Global Solid Oral Nutraceutical Excipient Market Research Report 2024

Global Semi Solid Formulations Drug Delivery Market Research Report 2025

Vigabatrin Powder for Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Risperidone Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cosmetics Development and Formulation Market Research Report 2024

Transdermal Drug Delivery Formulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Aripiprazole Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CNS Oral Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions